Journal article

Combination chemotherapy for myelomatosis.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Clarke, M., Gray, R., Dunn, J., & MacLennan, I. (1992). Combination chemotherapy for myelomatosis. Lancet, 340(8816), 433.

MLA Style

Clarke, M., et al. “Combination Chemotherapy for Myelomatosis.” Lancet, vol. 340, no. 8816, 1992, p. 433.

Chicago Style

Clarke, M, R Gray, J Dunn, and I MacLennan. 1992. “Combination Chemotherapy for Myelomatosis.” Lancet 340 (8816): 433.
Share
Print

Access Document

Publisher copy:: 10.1016/0140-6736(92)91520-i

Authors

+ Clarke, M More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author

+ Gray, R More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author

+ Dunn, J More by this author

Role:: Author

+ MacLennan, I More by this author

Role:: Author

Journal:: Lancet More from this journal
Volume:: 340
Issue:: 8816
Pages:: 433
Publication date:: 1992-08-01
DOI:: 10.1016/0140-6736(92)91520-i
EISSN:: 1474-547X
ISSN:: 0140-6736

Language:: English
Keywords:: Cyclophosphamide

Carmustine

Humans

Melphalan

Doxorubicin

Antineoplastic Combined Chemotherapy Protocols

Multiple Myeloma
Pubs id:: pubs:79291
UUID:: uuid:bcddbb31-c2f9-4a58-99e4-f2127165ca62
Local pid:: pubs:79291
Source identifiers:: 79291
Deposit date:: 2012-12-19

Terms of use

Copyright date:: 1992

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP